A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether using the cephalic vein from the arm for coronary artery bypass grafts achieves an adequate patency rate. Only 219 papers were identified on Medline using the reported search and hand-searching of reference lists. Fourteen papers represented the best evidence on the topic. The author, journal, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses were tabulated. The patency rate seems to be in the order of 50% at around three years for cephalic veins used for coronary bypass grafting, and this was variable. In addition, we identified only 181 cephalic veins used for coronary bypass grafting in the literature from seven papers. In lower extremity bypass procedures over 900 uses of the cephalic vein have been documented but again patency seems to be around 50% at three to five years. Arterialisation of the vein using an arteriovenous fistula, or angioscopy, have both been used as an attempt to improve patency. In addition, a large proportion of the reported cephalic veins for coronary grafting were used for sequential bypass grafting which may have affected patency rates. Thus, in summary, the patency of the cephalic vein used for coronary artery bypass grafting is around 50% at three years.
Introduction
A best evidence topic was constructed according to the structured protocol. This protocol is fully described in the ICVTS w1x.
Clinical scenario
You are referred a diabetic 78-year-old gentleman with left main stem disease and triple vessel disease. He has severe varicose veins in both his legs, but he has a large first diagonal artery and you would like to place four grafts. You would like to use the left internal mammary artery, and both radial arteries and you wonder whether you could also use a cephalic vein from his arm. You resolve to check the patency of these veins in the literature prior to proceeding.
Three-part question
In wpatients undergoing coronary artery bypass surgeryx, is the use of the wcephalic veinx associated with acceptable wvein graft patencyx. 
Search strategy

Search outcome
A total of 219 papers were identified using the reported search. Seven papers documenting the patency of the cephalic vein for coronary bypass grafting and the largest series of cephalic veins for a lower extremity bypass were documented. In addition, another six papers on lower extremity grafting with cephalic veins were briefly reviewed but not tabulated ( Table 1) . were patent at mean 25 months while 7 (12.5%) of the patent grafts had localised stenoses.
Results
Licht
Jarvinen et al. w5x reported the patency of 16 cephalic veins in 15 patients. At a mean follow up of 1.4 years (1-42 months), 87% (27y31 distal anastomoses) were patent angiographically although three veins also had aneurysmal dilatation.
Prieto et al. w6x examined 10 patients at different intervals. The early patency of arm vein grafts in six patients studied less than nine months after operation was 9 out of 10 grafts (90%). Four patients were followed for more than one year, after which time five out of eight grafts (63%) were patent, two of them with gross abnormalities.
Seifert et al. w7x studied 17 patients at eight months follow up, out of 35 grafts only 23 (66%) were patent. There were attempts to address the issue of delicate thin wall and poor handling of arm veins by creating arteriovenous fistulae to arterialise the vein before using it for bypass grafting. Faries et al. w8x reported the cephalic vein graft patency of 520 lower limb bypass procedures up to 1998. Patency was assessed regularly using Doppler ultrasound and interestingly on harvesting, half of the veins had an angioscopy performed and luminal integrity was assessed, resulting in 30% of veins being spliced to resect an abnormal section. The three-year patency was 69%, and the five-year patency was 55%.
Mehta et al. w9x reported a case where two cephalic arterialised veins were used. One vein lasted at least seven years and the other was patent at 11 years. We identified several other studies that documented the use of the cephalic vein for lower extremity bypass. We did not tabulate these but the patency was: Schulman w10x in 64 patients, five-year patency 31% for femoropopliteal bypass and 15% for femorotibial bypass; Holzenbein w11x in 250 cephalic vein grafts, three-year patency 52%; Harris w12x in 67 patients, 68% at five years; Brochado-Neto w13x in 35 cephalic veins: 42% two-year patency; Harward w14x Downloaded from https://academic.oup.com/icvts/article-abstract/6/2/251/834715 by guest on 29 January 2019 in 43 patients, 49% at three years; Seston w15x in 34 patients 40% three-year patency.
Clinical bottom line
The patency rate seems to be in the order of 50% at around three years for cephalic veins used for coronary bypass grafting, and this was variable. In addition, we identified only 181 cephalic veins used for coronary bypass grafting in the literature. In lower extremity bypass procedures over 900 uses of the cephalic vein have been documented but again patency seems to be around 50% at three to five years. Arterialisation of the vein using an arteriovenous fistula, and angioscopy have both been used as an attempt to improve patency in some papers. In addition, a large proportion of the reported cephalic veins for coronary grafting were used for sequential bypass grafting which may have affected patency rates. Thus, in summary the patency of the cephalic vein used for coronary arterial bypass grafting is around 50% at three years.
